Pfizer has concluded a global licensing agreement with 3SBio, excluding China, which grants it exclusive rights for the 3SBio’s SSGJ-707.

Industry Veteran and Former Pfizer Chief Scientific Officer Brings Extensive R&D and Leadership Experience to Advance BenchSci's Mission of Improving the Speed and Quality of Preclinical R&D ...

The antibody discovery market is expanding, driven by the increasing incidence of chronic conditions such as cancer, diabetes, and cardiovascular and ...

HBCU Fellow Tre’von Conner shares how the IKNS curriculum at Columbia is helping him learn how to effectively tackle ...

MSD has joined fellow big pharmas in looking to redirect cash, as the drugmaker revealed plans to save $3bn annually by the end of 2027.

The International Chamber of Commerce (ICC), the world business organization representing more than 4.5-million-member ...

SmallCap stocks can often be overlooked by institutional investors, yet they offer outsized return potential for those ...

Supporting cutting-edge research at colleges and universities — even, or especially, in its earliest stages, before anyone ...

Quotient Sciences Announces Formation of Scientific Advisory Board Advisory board will contribute to driving innovation and technology aligned with Company strategic priorities Inaugural board ...

Strengthens Board of Directors with appointment of two new independent members, increasing independent representation to greater than 90%Underscores Royalty Pharma’s commitment to enhanced corporate ...